South East African Combination Anti-malarial Therapy (SEACAT) Evaluation.
A Joint project by Mozambique,South Africa and Swaziland to study the effect of anti-malarial therapy on the emergence of resistance, initiated through the Regional Malaria Control Commission of the
Lubombo Spatial Development Initiative
Collaborators include:
| University of Cape Town, Department of Pharmacology |
| Medical Research Council |
| Lubombo Spatial Development Initiative |
| South African National Department of Health |
| Swaziland Department of Health |
| Mozambique Department of Health |
| KZN Provincial Department of Health |
| Northern Province Department of Health |
| Mpumalanga Department of Health |
| London School of Hygiene and Tropical Medicine |
| Centres for Disease Control |
| The South East African Combination Antimalarial Therapy [SEACAT] evaluation, receives financial support from the UNDP / World Bank / WHO Special Programme for Research and Training in Tropical Diseases [TDR]. | 
|
Contact The Webmaster Logo designed and sponsored by Brown KSDP